BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15788471)

  • 1. Lower HDL-C and apolipoprotein A-I are related to higher glomerular filtration rate in subjects without kidney disease.
    Krikken JA; Gansevoort RT; Dullaart RP;
    J Lipid Res; 2010 Jul; 51(7):1982-90. PubMed ID: 20211930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein modulation of proteinuric renal injury.
    Tsuchida Y; Zhong J; Otsuka T; Dikalova A; Pastan I; Anantharamaiah GM; Linton MF; Yancey PG; Ikizler TA; Fogo AB; Yang H; Kon V
    Lab Invest; 2019 Jul; 99(8):1107-1116. PubMed ID: 31019291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidneys: key modulators of high-density lipoprotein levels and function.
    Yang H; Fogo AB; Kon V
    Curr Opin Nephrol Hypertens; 2016 May; 25(3):174-9. PubMed ID: 27008596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein.
    Kon V; Yang H; Fazio S
    Arch Med Res; 2015 Jul; 46(5):379-91. PubMed ID: 26009251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The experimental model of nephrotic syndrome induced by Doxorubicin in rodents: an update.
    Pereira Wde F; Brito-Melo GE; de Almeida CA; Moreira LL; Cordeiro CW; Carvalho TG; Mateo EC; Simões E Silva AC
    Inflamm Res; 2015 May; 64(5):287-301. PubMed ID: 25788426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of omega-3 fatty acid ethyl esters on the oxylipin composition of lipoproteins in hypertriglyceridemic, statin-treated subjects.
    Newman JW; Pedersen TL; Brandenburg VR; Harris WS; Shearer GC
    PLoS One; 2014; 9(11):e111471. PubMed ID: 25393536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutation in Ampd2 is associated with nephrotic syndrome and hypercholesterolemia in mice.
    Helmering J; Juan T; Li CM; Chhoa M; Baron W; Gyuris T; Richards WG; Turk JR; Lawrence J; Cosgrove PA; Busby J; Kim KW; Kaufman SA; Cummings C; Carlson G; Véniant MM; Lloyd DJ
    Lipids Health Dis; 2014 Oct; 13():167. PubMed ID: 25361754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced apolipoprotein glycosylation in patients with the metabolic syndrome.
    Savinova OV; Fillaus K; Jing L; Harris WS; Shearer GC
    PLoS One; 2014; 9(8):e104833. PubMed ID: 25118169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of apoE gene expression and its gene polymorphism with nephrotic syndrome susceptibility: a meta-analysis of experimental and human studies.
    Zhou TB; Qin YH; Xu HL
    Mol Biol Rep; 2012 Oct; 39(10):9347-54. PubMed ID: 22760259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein metabolism in experimental nephrosis.
    Marsh JB
    Proc Soc Exp Biol Med; 1996 Nov; 213(2):178-86. PubMed ID: 8931662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ineffectiveness of dietary protein augmentation in the management of the nephrotic syndrome.
    Al-Bander H; Kaysen GA
    Pediatr Nephrol; 1991 Jul; 5(4):482-6. PubMed ID: 1911126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graded effects of proteinuria on HDL structure in nephrotic rats.
    Shearer GC; Newman JW; Hammock BD; Kaysen GA
    J Am Soc Nephrol; 2005 May; 16(5):1309-19. PubMed ID: 15788471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrotic livers secrete normal VLDL that acquire structural and functional defects following interaction with HDL.
    Shearer GC; Couser WG; Kaysen GA
    Kidney Int; 2004 Jan; 65(1):228-37. PubMed ID: 14675054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of apolipoprotein gene expression and plasma high-density lipoprotein composition in experimental nephrosis.
    Marshall JF; Apostolopoulos JJ; Brack CM; Howlett GJ
    Biochim Biophys Acta; 1990 Feb; 1042(3):271-9. PubMed ID: 2306478
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.